Here's Why Bristol Myers Squibb Stock Is A Better Pick Over This Pharmaceutical Bellwether
27/2 13:05
We think that Bristol Myers Squibb stock (NYSE: BMY) currently is a better pick compared to its industry peer Johnson & Johnson stock (NYSE: JNJ), given its better growth prospects and comparatively lower valuation of 3.2x trailing revenues, compared to 4.5x for J...